The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
First Trust Nasdaq Pharmaceuticals ETF FTXH
Morningstar’s Analysis FTXH
Will FTXH outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 54.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Pfizer Inc | 7.43 | 1.5 Mil | Healthcare |
Bristol-Myers Squibb Co | 7.41 | 1.5 Mil | Healthcare |
AbbVie Inc | 7.28 | 1.5 Mil | Healthcare |
Merck & Co Inc | 7.06 | 1.5 Mil | Healthcare |
Johnson & Johnson | 6.91 | 1.4 Mil | Healthcare |
Amgen Inc | 3.68 | 763,597 | Healthcare |
Eli Lilly and Co | 3.68 | 763,276 | Healthcare |
Gilead Sciences Inc | 3.59 | 745,244 | Healthcare |
Regeneron Pharmaceuticals Inc | 3.57 | 740,006 | Healthcare |
Cardinal Health Inc | 3.57 | 739,573 | Healthcare |